AGLE
Closed
Aeglea Bio Therapeutics Inc
27.6
-0.1 (-0.36%)
Last Update: 30 Jan 2024 17:30:00
Yesterday: 27.66
Day's Range: 26.6 - 28.0899
Send
sign up or login to leave a comment!
When Written:
0.2871
Aeglea Bio Therapeutics Inc. is a biotechnology company that focuses on developing enzyme-based therapeutics for the treatment of rare genetic diseases and cancer. The company was founded in 2013 and is headquartered in Austin, Texas.
Aeglea's lead product candidate is pegzilarginase, an enzyme therapy for the treatment of Arginase 1 Deficiency, a rare genetic disorder that causes a deficiency in the enzyme arginase. The company is also developing other enzyme therapies for the treatment of cancer, including AEB1102, which targets the amino acid metabolism pathway in cancer cells.
Aeglea's approach to developing enzyme therapies involves modifying naturally occurring enzymes to increase their therapeutic potential. The company's proprietary technology platform, called Aeglea Engineered Enzymes, allows for the creation of enzymes with improved pharmacokinetic properties and increased potency.
Aeglea is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol AGLE.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Aeglea's lead product candidate is pegzilarginase, an enzyme therapy for the treatment of Arginase 1 Deficiency, a rare genetic disorder that causes a deficiency in the enzyme arginase. The company is also developing other enzyme therapies for the treatment of cancer, including AEB1102, which targets the amino acid metabolism pathway in cancer cells.
Aeglea's approach to developing enzyme therapies involves modifying naturally occurring enzymes to increase their therapeutic potential. The company's proprietary technology platform, called Aeglea Engineered Enzymes, allows for the creation of enzymes with improved pharmacokinetic properties and increased potency.
Aeglea is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol AGLE.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!